Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.34 |
| ▸ | PGK2 | P07205 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SLC11A2 | P49281 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6916944 | 0.85 | PON1 (0.33) | — | |
| SCHEMBL5872351 | 0.83 | PGK1 (0.37) | PGK1PGK2L3MBTL1SLC11A2 | |
| SCHEMBL2810221 | 0.82 | PGK1 (0.44) | PGK1PGK2L3MBTL1SLC11A2 | |
| SCHEMBL258408 | 0.77 | — | — | |
| SCHEMBL4445015 | 0.77 | — | — | |
| SCHEMBL27953149 | 0.74 | PON1 (0.32) | L3MBTL1 | |
| SCHEMBL21865896 | 0.74 | PON1 (0.36) | L3MBTL1 | |
| SCHEMBL10751824 | 0.74 | ALDH1A1 (0.38) | PGK1PGK2SLC11A2 | |
| SCHEMBL2917186 | 0.74 | — | — | |
| SCHEMBL9461239 | 0.73 | PGK1 (0.36) | PGK1PGK2SLC11A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2036204-A | — | — | None | — | — | JP | disclosed |
| US-20260049174-A1 | COPOLYMER AND ITS USE AS COATING | ETH ZUERICH (CH) | 2026-02-19 | — | — | US | disclosed |
| EP-4558540-A1 | COPOLYMER AND ITS USE AS COATING | ETH Zurich (CH) | 2025-05-28 | — | — | EP | disclosed |
| CN-119585338-A | Copolymers and their use as coatings | 苏黎世联邦理工学院 | 2025-03-07 | — | — | CN | disclosed |
| WO-2024017963-A1 | COPOLYMER AND ITS USE AS COATING | ETH ZUERICH (CH) | 2024-01-25 | — | — | WO | disclosed |
| CN-116490355-A | Compound, resin composition, resin sheet, resin cured product, and laminated substrate | TDK株式会社 | 2023-07-25 | — | — | CN | disclosed |
| CN-113677729-A | Epoxy resin, resin composition, resin sheet, cured resin, resin substrate, and laminated substrate | TDK株式会社 | 2021-11-19 | — | — | CN | disclosed |
| CN-113646292-A | Compound, resin composition, and polymerization product | TDK株式会社 | 2021-11-12 | — | — | CN | disclosed |
| CN-107406339-B | Method and apparatus for producing alpha-olefin oligomer | 三菱化学株式会社 | 2021-10-26 | — | — | CN | disclosed |
| CN-107074679-B | Method and apparatus for producing alpha-olefin oligomer | 三菱化学株式会社 | 2020-11-17 | — | — | CN | disclosed |
| EP-0863875-A1 | NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY | F. HOFFMANN-LA ROCHE AG (CH) | 1998-09-16 | — | — | EP | disclosed |
| WO-1998029401-A1 | AMINOEPOXIDES FROM AMINOALDEHYDES AND IN-SITU FORMED HALOMETHYL ORGANOMETALLIC REAGENT | G.D. SEARLE & CO. (US) | 1998-07-09 | — | — | WO | disclosed |
| WO-1998005961-A1 | COMPOUNDS HAVING A PLURALITY OF NITROGENOUS SUBSTITUENTS | ISIS PHARMACEUTICALS, INC. (US) | 1998-02-12 | — | — | WO | disclosed |
| EP-0817787-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1997009311-A1 | NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY | F. HOFFMANN-LA ROCHE AG (CH) | 1997-03-13 | — | — | WO | disclosed |
| WO-1996030377-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-03 | — | — | WO | disclosed |
| US-5179066-A | THERMOSENSITIVE RECORDING MATERIAL | YAMADA CHEMICAL CO., LTD. (JP) | 1993-01-12 | — | — | US | disclosed |
| JP-H0236204-A | PRODUCTION OF ISOBUTYLENE-BASED POLYMER HAVING FUNCTIONAL TERMINAL | KANEGAFUCHI CHEM IND CO LTD | 1990-02-06 | — | — | JP | disclosed |
| US-4312861-A | Pharmaceutical compositions containing N-alkyl-N-(nuclearly-substituted) benzylamines having vasotonia-regulating activity | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-01-26 | — | — | US | disclosed |
| US-4107444-A | INTERMEDIATES FOR POLYESTERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049174-A1 | COPOLYMER AND ITS USE AS COATING | MSR1, OGFR, IGF2R | PGK1 4766/4885PGK2 4591/4885L3MBTL1 2903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.